Business Segments APTOCROM Inc.

Stocks

End-of-day quote Korea S.E. Other stock markets 2026-08-04			5-day change	1st Jan Change
1,650.00 ^KRW	-0.06%		+1.41%	-67.00%

06-30	Aprogen Biologics Inc. announced that it has received KRW 50.8 billion in funding from APTOCROM Inc.	CI
05-25	Aprogen Biologics Inc. announced that it expects to receive KRW 50.8 billion in funding from APTOCROM Inc.	CI

Breakdown by Business Segment (KRW)

Fiscal Period: December	2021	2022	2023	2024	2025
Pharmaceutical Division	7.15B	8.9B	8.77B	7.38B	6.87B
Total Assets	4.57B	10.88B	-	-	-
D&A	63.04M	44.21M	49.74M	9.03M	4.88M
Operating Income	-547M	-5.47M	516M	361M	-643M
Total Assets	-	2.97B	-	-	-
Total Assets	-	2.41B	-	-	-
Insulation Division	-	-	6.37B	8.46B	2.42B
D&A	-	-	272M	209M	142M
Operating Income	-	-	741M	1.97B	-1.18B
Rental Division	524M	524M	508M	521M	518M
Total Assets	31.23B	195B	-	-	-
D&A	226M	236M	221M	218M	218M
Operating Income	275M	-984M	-1.17B	-1.29B	-528M
Game Business Division	738M	173M	358M	39.49M	-
Total Assets	1.11B	563M	-	-	-
D&A	124M	8.64M	6.67M	1.67M	-
Operating Income	-2.31B	58.81M	100M	-66.34M	65.04M
Wireless Solutions Business	-	-	-	-	-
Total Assets	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-
Total Assets	190B	1.56B	-	-	-
Illumination Control Business	-	-	-	-	-
Total Assets	-	-	-	-	-
D&A	-	-	-	-	-
Operating Income	-	-	-	-	-

Geographical breakdown of sales (KRW)

Fiscal Period: December	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets						-	-	-	-	286B